RHOA and ovarian carcinoma: Within the lipid-rich ascites of ovarian cancer, PUFAs inhibit RhoA-GTPase activity, leading to the downregulation of nuclear YAP1, a critical transcription factor in the Hippo pathway, which dampens antitumor immune responses.